Lipoprotein (a) [Lp(a)] was first described by Berg as a genetic variant of low density lipoprotein (LDL) more than twenty-five years ago (1) . Lp(a) lipid composition is similar to that of LDL, and floats in a density range of 1.05-1.125g/ml. Its protein moiety contains a specific glycoprotein, apolipoprotein (a) [apo(a)], in addition to apo B-100. Recently, the cDNA sequence of human apo(a) was determined, and it shows a striking homology with plasminogen (2) . This finding may provide a direct link between thrombogenesis and progressive atherosclerosis. We examined the association between Lp(a) concentrations and angiographically assessed atherosclerosis in coronary artery disease and cerebrovascular disease.
Subjects and Methods
Serum lipid and Lp(a) concentrations were measured in 87 patients with acute myocardial infarction (AMI group) admitted to the Coronary Care Unit (CCU) at the National Cardiovascular Center (NCVC) and in 49 patients with cerebrovascular disease (CVD group) admitted to the Stroke Care Unit (SCU) at NCVC. Eighty-five apparently healthy individuals examined for general medical check up were used as controls (Cont group). All subjects were males under 80 years of age. Blood samples were drawn from the fasting patients early the next morning after hospital admission.
VLDL was separated by ultracentrifugation, and the cholesterol (Ch) and triglyceride (TG) content were determined. HDL-Ch was measured by a precipitation method, and the LDL-Ch level was calculated as the serum Ch level minus the sum of VLDL-Ch and HDL-Ch. Serum Lp(a) levels were determined using a single radial immunodiffusion technique, with a specific antibody against human Lp(a).
In the 76 AMI patients, coronary angiography was performed using either the Judkins or Sones technique. We analyzed the angiographic findings by two different methods : 1) Patients were subdivided into groups with one-, two-, or three-vessel disease defined as 75 percent or greater narrowing of the transluminal diameter of the left anterior descending artery (LAD), the left circumflex artery (LCX), or the right coronary artery (RCA) ; 2) Coronary arteries were divided into segments according to the American Heart Association Committee Report (3) . In each segment, we evaluated the extent of stenosis and calculated the coronary index (C.I.) by modified Balcon's method (4) . In this C.I., the lower score indicates the more severe lesion. Forty-two CVD patients underwent four-vessel cerebral arteriograms.
The cerebral arteries were divided into extracranial and intracranial, as described by Mathew et al. (5) . In this study, we examined atherosclerotic lesions limited to the extracranial arteries (ECA) and major intracranial arteries (ICA).
In addition, we analyzed serum Lp(a) levels, apo E phenotypes, and apo(a) isoforms in healthy children aged 7, 10, and 13 years.
Family members of some children were also examined.
Serum Lp(a) was measured by enzyme-immunoassay (Macra Lp(a), Terumo Medical Corporation) and apo E phenotyping was performed by immunoblotting of isoelectric focusing from serum. Apo (a) phenotyping was performed by the method described by Utermann (6).
Results and Discussion
Serum lipoprotein profile and frequency distributions of serum Lp(a) concentrations in each group are shown in Table 1 and Fig. 1 , respectively.
The mean age in the AMI and CVD groups was older than that in the Cont group. HDL-Ch was significantly lower in the AMI and CVD groups compared to that in the Cont group, but there were no differences in Ch and TG levels. When we set the same tendency with age as described above. However, all the AMI subgroups had a higher frequency of elevated Lp(a) values than the Cont group ; especially, over the age of 70, the frequency was much higher than that in the Cont group (41% vs. 11%). We postulated that individuals with higher LDL levels developed ischemic heart disease at a rather young age, while those with lower levels developed atherosclerosis at a later age due to risk factors other than hyperlipoproteinemia.
It was suggested that one risk factor was a high Lp(a) level.
In normocholesterolemic patients who underwent coronary angiography, the relationship between the number of affected vessels and serum Lp(a) levels was studied. The frequency of elevated Lp(a) levels increased with increases in the number of affected vessels (Table 3) , and the severity of coronary artery disease appeared to correlate well with the Lp(a) level. We calculated the coronary index (C.I.) and evaluated the correlation between C.I. and Lp(a) concentrations in the AMI group (Fig. 2) . Lp(a) levels inversely correlated with C.I. ; C.I. tended to decrease as Lp(a) level increased.
In addition, univariate, nonparametric correlation between C.I. and variables (age, lipid, and lipoprotein) was studied in the AMI group. C.I. did not correlate with age, Ch, or HDL-Ch. However, there was a significant correlation between C.I. and LDL-Ch (rs = -0.23, p < 0.05). Furthermore, Lp(a) concentrations showed a stronger correlation with C.I. (rs = In the AMI normocholesterolemic group, we evaluated the mean C.I. in subgroups with and without high Lp(a) levels. The mean C.I. in patients with high Lp(a) values was lower than in those with low Lp(a) values.
Moreover, there was a significant correlation between C.I. and Lp(a) levels even in normocholesterolemic subjects (rs = -0.33, p < 0.02).
In the CVD group, the frequency of high Lp(a) levels was significantly higher than in the Cont group (Table 2 ). In the normocholesterolemic subjects, however, there were no significant differences in the frequency of elevated Lp(a) levels between the CVD group and Cont group. The CVD normocholesterolemic group was further divided into 4 subgroups : 1) those with cerebral embolism (EMB group) ; 2) those with cerebral hemorrhage (HEM group) ; 3) those with cerebral thrombosis (THR group) ; and 4) Table 4 . Frequency of subjects with elevated Lp(a) levels in normocholesterolemic CVD subgroups. Table 5 . Serum lipids and lipoprotein(a) in healthy individuals according to apo(a) isoforms. Table 6 . Serum lipids and lipoprotein(a) in healthy children according to apo E phenotypes.
those with lacunar infarcts (LAC group). In the THR group, Lp(a) levels were significantly higher than those in the Cont and LAC groups ( Table 4 ). The frequencies of elevated Lp(a) levels in both HEM group and EMB group did not significantly differ from that in the Cont group. In CVD normocholesterolemic subjects, the severity of cerebral artery lesions was studied by angiography.
In both extracranial vessels and major intracranial vessels, patients with high Lp(a) levels showed severe lesions. These results suggest that even in normocholesterolemic subjects, elevated serum Lp(a) levels are linked to atherosclerosis of the coronary and cerebral arteries and influence its severity.
Serum levels of Lp(a) vary from almost undetectable to more than 100 mg/dl. The apparent molecular weight of apo(a) ranges from 450 to 750 kD. Utermann suggested that the size of apo(a) is genetically controlled, and there is an inverse relationship between the size of apo(a) and plasma Lp(a) concentrations (6) . We analyzed apo(a) isoforms and serum Lp(a) levels in healthy subjects (Table  5 ). Our observations concur with those of Utermann. Although a strong correlation was obtained within each family, we found wide variations of Lp(a) values in each apo(a) isoform group among different families (Fig. 3) . Determining other genetic and metabolic factors influencing the plasma Lp(a) concentration in individuals is important.
We demonstrated that subjects with an E3/2 phenotype of apolipoprotein E had reduced serum cholesterol levels, and those with an E4/3 phenotype had increased levels, even in childhood (7, 8) . It was also suggested that hypercholesterolemic patients tend to have higher serum Lp(a) concentrations than normocholesterolemic individuals. We investigated Lp(a) levels in healthy children according to apoE phenotype ( Table 6 ). The same tendency in serum Lp(a) concentration with apo E phenotype was also observed for cholesterol concentration.
The apo E phenotype may be one of the genetic factors influencing serum Lp(a) levels through cholesterol metabolism.
